MDC Financials: Results, Ratios & Statements | Medlab Clinical | Shorted

⌘K

MDC

Pharmaceuticals, Biotechnology & Life Sciences

Medlab Clinical

Short interest: 0.02%; 0.00 pp 30d; as of 31 Aug 2021
Reported shorts: 59.8K
Shares on issue: 342.176M

Fundamentals

Our data providers hold no financial statements for MDC (last checked 14 Oct 2026). The company's own filings are listed below.

Financial reports

The company's own filings, newest first

Quarterly Activities/Appendix 4C Cash Flow Report
Quarterly Report3 Feb 2025via asx_announcements
Annual Report to shareholders
Annual Report4 Nov 2024via asx_announcements
Quarterly Activities/Appendix 4C Cash Flow Report
Quarterly Report31 Oct 2024via asx_announcements
Quarterly Activities/Appendix 4C Cash Flow Report
Quarterly Report31 Jul 2024via asx_announcements
Half Yearly Report and Accounts
Half Year Results15 May 2024via asx_announcements
Quarterly Activities/Appendix 4C Cash Flow Report
Quarterly Report30 Apr 2024via asx_announcements
MDC Annual Report to shareholders
Annual Report24 Apr 2024via asx_announcements
Addendum to 2023 Annual Report - Shareholder Information
Annual Report24 Apr 2024via asx_announcements
Quarterly Activities/Appendix 4C Cash Flow Report
Quarterly Report31 Jan 2024via asx_announcements
MDC HY23 Interim Report
Half Year Results9 Jan 2024via asx_announcements

Showing 10 of 20 reports